PROSPECTIVE EVALUATION OF 68-GA-PROSTATE SPECIFIC MEMBRANE ANTIGEN (PSMA)-POSITRON EMISSION TOMOGRAPH (PET) AND EARLY PROSTATIC SPECIFIC ANTIGEN (PSA) KINETICS DURING SALVAGE RADIOTHERAPY FOR PERSONALIZING THE MANAGEMENT OF MEN WITH RELAPSE OF PROSTATE CANCER AFTER RADICAL PROSTATECTOMY: